<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://repozitorij.uni-lj.si/IzpisGradiva.php?id=174360"><dc:title>Microfluidics-based generation and immobilization of nanoscale cross-linked enzyme aggregates for continuous transamination</dc:title><dc:creator>Menegatti,	Tadej	(Avtor)
	</dc:creator><dc:creator>Lavrič,	Žan	(Avtor)
	</dc:creator><dc:creator>Hlebanja,	Patrik	(Avtor)
	</dc:creator><dc:creator>Žnidaršič Plazl,	Polona	(Avtor)
	</dc:creator><dc:subject>amine transaminase</dc:subject><dc:subject>enzyme immobilization</dc:subject><dc:subject>cross-linked enzyme aggregates</dc:subject><dc:subject>membrane microreactor</dc:subject><dc:subject>flow biocatalysis</dc:subject><dc:description>Cross-linked enzyme aggregates (CLEAs) offer a cost-effective and robust strategy for enzyme immobilization, combining high recovered activity with improved operational stability—key traits for continuous biocatalysis. However, conventional batch preparation methods typically yield heterogeneous, micrometer-sized particles with poor reproducibility, mechanical fragility, and limited applicability in continuous reactor systems. In this study, we introduce a novel microfluidic approach for generating stable, uniform nanoscale CLEAs of amine transaminase (ATA-CLEAs). By spatially separating acetone-induced precipitation and glutaraldehyde cross-linking into connected microfluidic sections, we enabled independent optimization of both steps. This system yielded highly uniform ATA-CLEAs (∼100 nm diameter) with up to 90.5 % recovered activity—2.5-fold higher than batch-prepared aggregates— while reducing processing time and reagent consumption. Additionally, we demonstrate the first integration of CLEA synthesis with a membrane microreactor, enabling one-step purification and immobilization with 100 % yield. Upon connection to a substrate feed, the system was seamlessly adapted for continuous transamination of (S)-α-methylbenzylamine with pyruvate, achieving over 68 % immobilization efficiency. The immobilized ATA-CLEAs demonstrated superior operational stability compared to their non-aggregated counterparts, delivering a 45 % higher turnover number over five days of continuous operation. This work establishes a scalable and efficient platform for incorporating CLEAs into continuous biocatalytic processes—an essential advancement in green engineering for the sustainable production of pharmaceuticals and fine chemicals.</dc:description><dc:date>2025</dc:date><dc:date>2025-10-01 14:01:02</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>174360</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
